Cost‐effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Volume: 6, Issue: 2, Pages: 310 - 321
Published: Mar 1, 2018
Abstract
Background In clinical practice, treatment sequences of biologicals are applied for active fistulising Crohn’s disease, however underlying health economic analyses are lacking. Objective The purpose of this study was to analyse the cost-effectiveness of different biological sequences including infliximab, biosimilar-infliximab, adalimumab and vedolizumab in nine European countries. Methods A Markov model was developed to compare treatment...
Paper Details
Title
Cost‐effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe
Published Date
Mar 1, 2018
Volume
6
Issue
2
Pages
310 - 321
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.